Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Sun Pharma"
Count: 120
Selected: 0
| NCT ID | Title |
|---|
| NCT03997786 | A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis | ||
| NCT04991116 | Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis | ||
| NCT04314544 | Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) | ||
| NCT04314531 | Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2) | ||
| NCT03897075 | Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis | ||
| NCT03897088 | Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasi | ||
| NCT03192137 | Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery | ||
| NCT04487860 | Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo | ||
| NCT02980692 | Efficacy and Safety Study of SUNPG1623 | ||
| NCT01722331 | A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010) | ||
| NCT01808547 | Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects | ||
| NCT01576952 | Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects | ||
| NCT01387464 | Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery | ||
| NCT01190878 | Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers | ||
| NCT01408082 | Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis | ||
| NCT00578955 | Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis | ||
| NCT01478555 | A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease | ||
| NCT00754949 | Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis | ||
| NCT04357795 | Effect of Cequa™ in Subjects With Dry Eye Disease | ||
| NCT01543490 | Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects | ||
| NCT03552276 | Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab. | ||
| NCT01729754 | A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011) | ||
| NCT02980705 | Efficacy and Safety Study of SUNPG1622 | ||
| NCT03718299 | A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis | ||
| NCT02737332 | A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer | ||
| NCT03192150 | 2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery | ||
| NCT03992729 | Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab | ||
| NCT02534896 | To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis | ||
| NCT03927443 | A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension | ||
| NCT02962284 | One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™ | ||
| NCT02254265 | Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca | ||
| NCT02845674 | An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca | ||
| NCT02688556 | Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca | ||
| NCT01936688 | A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012) | ||
| NCT04242953 | Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects | ||
| NCT03055143 | Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer | ||
| NCT04942054 | A Study in Patients With Advanced Breast Cancer | ||
| NCT03655236 | PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706 | ||
| NCT03450629 | Evaluation of Safety and Efficacy of Brimonidine Tartrate Ophthalmic Suspension | ||
| NCT03426267 | Evaluation of Efficacy and Safety of SDN-037 | ||
| NCT00947661 | Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension | ||
| NCT00945958 | Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension | ||
| NCT02629692 | Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment Refractory/Intolerant CML Failing ≥3 Prior CML Therapies | ||
| NCT02597465 | A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507 | ||
| NCT04332549 | To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer | ||
| NCT02970019 | Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease | ||
| NCT03445338 | To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers | ||
| NCT01457352 | Efficacy and Safety of SPARC0921 in Subjects With Spasticity | ||
| NCT03316820 | Bioavailability Study of K0706 in Healthy Subjects | ||
| NCT03109249 | Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer |
